T1	intervention 10 31	manual lymph drainage
T2	intervention 62 78	exercise therapy
T3	condition 82 97	arm lymphoedema
T4	location 346 361	Leuven, Belgium
T5	No-of-participants 363 366	160
T6	eligibility 379 452	patients with breast cancer and unilateral axillary lymph node dissection
T7	intervention-participants 751 753	79
T8	control 898 911	control group
T9	control-participants 917 919	81
T10	control 950 979	without manual lymph drainage
T11	outcome-Measure 981 1020	Cumulative incidence of arm lymphoedema
T12	outcome-Measure 1025 1056	time to develop arm lymphoedema
T13	outcome 1267 1312	cumulative incidence rate for arm lymphoedema
T14	intervention-value 1360 1363	24%
T15	control-value 1384 1387	19%
T16	outcome 1457 1488	time to develop arm lymphoedema
